He Yu
Sichuan University
23 Papers
37 Citations
He Yu is an academic researcher from Sichuan University. The author has contributed to research in topics: Lung cancer & Adenocarcinoma. The author has an hindex of 7, co-authored 23 publications.
Chat about Author
Papers
Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China.
TL;DR: An early warning model incorporating clinical characteristics that could be quickly obtained on admission is established and can be used to help predict severe COVID-19 and identify patients at risk of developing severe disease.
Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
TL;DR: There is no evidence to support the use of umifenovir for improving patient‐important outcomes in patients with COVID‐19 and the results of sensitivity analysis and subgroup analysis were similar to pooled results.
108
The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Li Zhang,Dan Liu,Lei Li,Dan Pu,Ping Zhou,Yuting Jing,He Yu,Yanwen Wang,Yihan Zhu,Yanqi He,Yalun Li,Shuang Zhao,Zhixin Qiu,Weimin Li +13 more
TL;DR: CYFRA21-1 levels had stronger association with metastases and survival status than CEA and NSE in all lung cancer patients and Cox regression results indicated that CYFRA 21-1 could act as independent prognostic factor in different stages of lung cancer.
Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19).
TL;DR: Wang et al. as mentioned in this paper explored the prognostic value of blood urea nitrogen (BUN) to serum albumin ratio (BAR) and further developed a prediction model for critical illness in COVID-19 patients.
Multidetector computed tomography angiography prior to bronchial artery embolization helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries and improve hemoptysis-free early survival rate in patients with hemoptysis
TL;DR: Preprocedural MDCT angiography helps detect culprit ectopic bronchial arteries and non-bronchial systemic arteries originating from subclavian and internal mammary arteries during BAE, and can improve the hemoptysis-free early survival rate, which could be recommended as a regular examination prior to BAE in patients with hemiptysis.
35